Core Viewpoint - ST凯利's board approved a proposal to grant 2.7 million yuan in bonuses for 2024 to senior management, despite significant profit declines compared to the previous year [1][2] Group 1: Management Decisions - The board appointed Hui Yiwei as the new vice president with an annual salary of 540,000 yuan, effective from the date of board approval [1] - The proposal for the 2024 bonuses was passed with 5 votes in favor and 2 against, with dissenting votes from board member Jin Shiqiang and independent director Di Zhaoping [2] Group 2: Financial Performance - In 2024, ST凯利 reported revenues of 985 million yuan, a year-on-year increase of 2.96%, but faced significant losses with operating profit and total profit at -107 million yuan and -110 million yuan, respectively, marking declines of 176.39% and 182.63% [3] - The net profit attributable to shareholders was -106 million yuan, with a non-recurring net profit of -65.31 million yuan, reflecting declines of 193.80% and 205.93% year-on-year [3] Group 3: Strategic Moves - ST凯利 plans to sell a 36.9% stake in Jieno Medical Management Group to Shanghai Huitian Medical Technology for 162 million yuan, as part of a strategy to exit investments in Jingzheng Medical [3] - Jieno Medical reported revenues of 282 million yuan and 126 million yuan for 2024 and January-May 2025, respectively, with net profits of 16.98 million yuan and 15.22 million yuan [3]
A股公司拟为高管发270万奖金,却遭两董事投票反对!什么情况?